Liver transplant for hepatocellular carcinoma: A heavyweight therapeutic option in need of a new policy on liver graft allocation

Dig Liver Dis. 2018 Dec;50(12):1351-1352. doi: 10.1016/j.dld.2018.09.018. Epub 2018 Sep 27.

Authors

Massimo Iavarone¹, Federica Invernizzi²

Affiliations

¹ CRC "A. M. & A. Migliavacca" Center for the Study of Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Maggiore Hospital, University of Milan, Milan, Italy. Electronic address: massimo.iavarone@gmail.com.
² CRC "A. M. & A. Migliavacca" Center for the Study of Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Maggiore Hospital, University of Milan, Milan, Italy.

PMID: 30316790
DOI: 10.1016/j.dld.2018.09.018

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Hepatocellular*
Humans
Liver Neoplasms
Liver Transplantation*
Tissue and Organ Procurement